Company Search:
Advanced Search
Sponsored Links
Silence Therapeutics Plc Company Snapshot
Silence Therapeutics Plc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Silence Therapeutics Plc with three other companies in this sector in the United Kingdom: Reneuron Group PLC (2014 sales of £22,000.00 [US$27,261.52 ] of which 100% was Cell-Based Therapies), Provexis PLC (£3,967.00 [US$4,915.75 ] ), and Tissue Regenix Group PLC (£6,000.00 [US$7,434.96 ] of which 100% was Tissue Engineering&Regenerative Medicine).

Sales Analysis. Sales fell dramatically in 2014: Silence Therapeutics Plc reported sales of £15,000.00 (US$18.59 thousand) for the year ending December of 2014. This represents a sharp decrease of 87.2% versus 2013, when the company's sales were £117,000.00 .
  Stock Performance Chart for Silence Therapeutics Plc
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 89.25p
(Figures in Pounds Sterling)
1 Week 0.3%   13 Weeks -11.6%  
4 Weeks -14.6%   52 Weeks -18.9%  
Silence Therapeutics Plc Key Data:
  Ticker: SLN Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2014 Sales 15,000
(Year Ending Jan 2015).
Employees: 56
  Currency: Pounds Sterling Market Cap: 62,297,949
  Fiscal Yr Ends: December Shares Outstanding: 69,801,624
  Share Type: Ordinary Closely Held Shares: 34,910,660
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.